{"id":"hopantenic-acid","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"pantocalcin","offLabel":[],"synonyms":["pantocalcin","calcium hopantenate","hopantenic acid","homopantothenic acid","D-Homopantothenic acid"],"timeline":[],"approvals":[],"brandName":"Pantocalcin","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your brain is a busy city with many different streets and intersections. Pantocalcin helps to regulate the flow of traffic by influencing the signals that control the movement of neurotransmitters, which are like the cars on the road. This can help to improve communication between different parts of the brain and alleviate symptoms of certain conditions.","oneSentence":"Pantocalcin works by modulating neurotransmitter activity in the brain.","technicalDetail":"Pantocalcin, a small molecule, is thought to exert its effects by interacting with neurotransmitter receptors and modulating the activity of neurotransmitters such as glutamate and GABA, which play critical roles in regulating neuronal excitability and synaptic plasticity."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3280","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=HOPANTENIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:54:14.216506","biosimilars":[],"competitors":[],"genericName":"hopantenic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"H473MVB16U","CHEBI":"CHEBI:134949","INN_ID":"2649","UMLSCUI":"C0122245","ChEMBL_ID":"CHEMBL2110783","KEGG_DRUG":"D08042","DRUGBANK_ID":"DB14044","PUBCHEM_CID":"28281","SECONDARY_CAS_RN":"76567-35-6"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":21,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pantocalcin, also known as Hopantenic Acid, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known if it is FDA approved or off-patent. The approved indications for Pantocalcin are also unknown. As a small molecule, it is likely to be administered orally, but its pharmacokinetic properties such as half-life and bioavailability are not well-documented. Further research is needed to understand the safety and efficacy of Pantocalcin.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}